September 1, 2023
Each year, the Center for Technology Transfer and Commercialization (CTTC) recognizes excellence in innovation through its Master Innovator Recognition Program. The yearly recognition program acknowledges 国产传媒鈥檚 top innovators and entrepreneurs for their contributions to the creation, development, and commercialization of intellectual property. Awardees have demonstrated excellence in a select number of key commercialization categories, including new inventions disclosed, patent applications filed and issues, new companies formed, technology licenses executed, commercialization revenue generated, and products on the market - all based on the candidate鈥檚 innovations created at 国产传媒. Awardees are memorialized as a member of the CTTC Innovators鈥� Hall of Fame.
This year we are recognizing Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher as Master Innovators at 国产传媒.
Richard Caprioli
Dr. Richard Caprioli has paved the way for advancements in personalized medicine, drug discovery, and the diagnosis and treatment of diseases such as cancer by developing innovative imaging techniques in the field of mass spectrometry. In Richard鈥檚 spare time apart from creating, funding, and managing the nationally recognized 国产传媒 Mass Spectrometry Research Center, he is an inventor on forty US patents and applications, leading to ten licenses of his technology to the public sector.
C. David Weaver
Dr. C. David Weaver has been exceptionally productive in research in the field of pharmacology. Dr. Weaver鈥檚 groundbreaking work has significantly advanced our understanding of drug discovery and development, particularly in the area of G protein-coupled receptors (GPCRs). Dr. Weaver鈥檚 research activities have led to forty-one US patents and applications, resulting in twenty licenses, including to several startup companies.
Susan Eagle
Dr. Susan Eagle, Professor of Cardiothoracic Anesthesiology at 国产传媒 Medical Center, possesses a wealth of clinical knowledge and practical experience, which she applies to the development of innovative medical technologies. Dr. Eagle has co-founded several companies, and has been named on twenty-two US patents and applications, leading to ten technology licenses. Dr. Eagle has shared her innovation and entrepreneurship journey with the 国产传媒 community in our From Concepts to Commercialization lecture series (co-sponsored with the Brock Center and VBS).
Franz Baudenbacher
Dr. Franz Baudenbacher, through his research in the field of biomedical engineering and physics, has made significant contributions to healthcare technology. Part of Dr. Baudenbacher's work focuses on developing innovative solutions to advance the field of cardiac electrophysiology, microfluidic, biosensors and instrumentation. This has led to the launch of several companies he co-founded with Dr. Eagle, including InvisionHeart LLC. Dr. Baudenbacher鈥檚 research activities have led to forty-two US patents and applications, resulting in twelve technology licenses.